Table 4.
Treatment Group | Baseline | 6-month | 1-year |
---|---|---|---|
FF | 12% | 36% | 32% |
WEB1 | 15% | 38% | 31% |
WEB2 | 21% | 44% | 41% |
Total | 16% | 39% | 35% |
Treatment Group | Baseline | 6-month | 1-year |
---|---|---|---|
FF | 12% | 36% | 32% |
WEB1 | 15% | 38% | 31% |
WEB2 | 21% | 44% | 41% |
Total | 16% | 39% | 35% |